Pertussis seroprevalence in Korean adolescents and adults using anti-pertussis toxin immunoglobulin G

Journal of Korean Medical Science

Volumn 29, Issue 5, 2014, Pages 652-656

  Lee, Soo Young ^a   Han, Seung Beom ^a   Young Bae, E ^a   Kim, Jong Hyun ^a   Kang, Jin Han ^a   Park, Yeon Joon ^a   Ma, Sang Hyuk ^b  

^a The Catholic University of Korea   (South Korea)

^b Changwon Fatima Hospital   (South Korea)

Author keywords

Korea; Pertussis vaccine; Prevalence; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGING; BLOOD; BORDETELLA PERTUSSIS; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; SOUTH KOREA; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; PERTUSSIS TOXIN; PERTUSSIS VACCINE; REPUBLIC OF KOREA; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84922392059     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2014.29.5.652     Document Type: Article

References (30)

1. Hewlett EL, Edwards KM. Clinical practice: pertussis-not just for kids. N Engl J Med 2005; 352: 1215-22.
2. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends. Int J Infect Dis 2012; 16: e850-4.
3. Brooks DA, Clover R. Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 2006; 19: 603-11.
4. Güriş D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28: 1230-7.
5. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005; 133: 159-71.
6. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000; 182: 1402-8.
7. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367: 1926-36.
8. Caro JJ, Getsios D, El-Hadi W, Payne K, O'Brien JA. Pertussis immunization of adolescents in the United States: an economic evaluation. Pediatr Infect Dis J 2005; 24: S75-82.
9. Tan T, Halperin S, Cherry JD, Edwards K, Englund JA, Glezen P, Greenberg D, Rothstein E, Skowronski D. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005; 24: S83-6.
10. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22: 3154-65.
11. Campins-Martí M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, Mertsola J, Oselka G, Ward J, Wirsing von König CH, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001; 20: 641-6.
12. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005; 24: S25-34.
13. Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, Cohen D. The seroepidemiology of Bordetella pertussis in Israel-estimate of incidence of infection. Vaccine 2010; 28: 3285-90.
14. Lee SY, Choi UY, Kim JS, Ahn JH, Choi JH, Ma SH, Park JS, Kim HM, Kang JH. Immunoassay of pertussis according to ages. Korean J Pediatr Infect Dis 2012; 19: 55-60.
15. Korea Centers for Disease Control and Prevention. Communicable diseases surveillance yearbook 2008. Seoul: Korea Centers for Disease Control and Prevention, 2009.
16. Korea Centers for Disease Control and Prevention. Infectious diseases surveillance yearbook 2011. Seoul: Korea Centers for Disease Control and Prevention, 2012.
17. Choi KM, Kim KH, Kim YJ, Kim JH, Park SE, Lee HJ, Eun BW, Jo DS, Choi EH, Hong YJ. Recommendation for the use of newly introduced Tdap vaccine in Korea. Korean J Pediatr 2011; 54: 141-5.
18. De Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, Mooi FR, Berbers GA. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 2010; 5: e14183.
19. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988; 296: 612-4.
20. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24: S58-61.
21. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B; Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32: 1691-7.
22. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044-6.
23. Kwon HJ, Yum SK, Choi UY, Lee SY, Kim JH, Kang JH. Infant pertussis and household transmission in Korea. J Korean Med Sci 2012; 27: 1547-51.
24. Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child 1978; 132: 371-3.
25. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007; 4: 15.
26. Forsyth K, Tan T, von König CH, Caro JJ, Plotkin S. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 2005; 24: S69-74.
27. Zhang Qi, Zheng H, Liu M, Han K, Shu J, Wu C, Xu N, He Q, Luo H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012; 12: 138.
28. Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine 2012; 30: 3566-71.
29. Lee SY, Kim JS, Ahn JH, Choi JH, Ma SH, Park JS, Kim HM, Kang JH. Immunoassay of diphtheria and tetanus according to ages. Infect Chemother 2012; 44: 62-6.
30. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761-6.